Gene · 215
Papers2,145
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,145
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Age and gender-specific reference intervals for a panel of lysophosphatidylcholines estimated by tandem mass spectrometry in dried blood spots. | Pract Lab Med | 2023 | 36618341 | PubTator, text mining | PubMed |
| Long-term cell fate and functional maintenance of human hepatocyte through stepwise culture configuration. | FASEB J | 2023 | 36607308 | PubTator, text mining | PubMed |
| Clinical and genetic characterization of NIPA1 mutations in a Taiwanese cohort with hereditary spastic paraplegia. | Ann Clin Transl Neurol | 2023 | 36607129 | PubTator, text mining | PubMed |
| Application value of whole exome sequencing in screening and identifying novel mutations of hypopharyngeal cancer. | Sci Rep | 2023 | 36596842 | PubTator, text mining | PubMed |
| Meeting FDA Guidance recommendations for replication-competent virus and insertional oncogenesis testing. | Mol Ther Methods Clin Dev | 2023 | 36588821 | PubTator, text mining | PubMed |
| Myelin lipid metabolism and its role in myelination and myelin maintenance. | Innovation (Camb) | 2023 | 36588745 | PubTator, text mining | PubMed |
| Endocrinopathies in Leukodystrophy. | Curr Probl Pediatr Adolesc Health Care | 2023 | 36588057 | PubTator, text mining | PubMed |
| Altered genome‑wide hydroxymethylation analysis for neoadjuvant chemoradiotherapy followed by surgery in esophageal cancer. | Exp Ther Med | 2023 | 36561617 | PubTator, text mining | PubMed |
| Neurocognitive and mental health impact of adrenoleukodystrophy across the lifespan: Insights for the era of newborn screening. | J Inherit Metab Dis | 2023 | 36527290 | PubTator, text mining | PubMed |
| The landscape of CRISPR/Cas9 for inborn errors of metabolism. | Mol Genet Metab | 2023 | 36525790 | PubTator, text mining | PubMed |
| Different effects of NK cells and NK-derived soluble factors on cell lines derived from primary or metastatic pancreatic cancers. | Cancer Immunol Immunother | 2023 | 36451048 | PubTator, text mining | PubMed |
| Paraganglioma with High Levels of Dopamine, Dopa Decarboxylase Suppression, Dopamine β-hydroxylase Upregulation and Intra-tumoral Melanin Accumulation: A Case Report with a Literature Review. | Intern Med | 2023 | 36384901 | PubTator, text mining | PubMed |
| The genetic and phenotypic spectra of adult genetic leukoencephalopathies in a cohort of 309 patients. | Brain | 2023 | 36380532 | PubTator, text mining | PubMed |
| Serum neutralization of SARS coronavirus 2 Omicron sublineages BA.1 and BA.2 and cellular immune responses 3 months after booster vaccination. | Clin Microbiol Infect | 2023 | 36257549 | PubTator, text mining | PubMed |
| Sex-specific newborn screening for X-linked adrenoleukodystrophy. | J Inherit Metab Dis | 2023 | 36256460 | PubTator, text mining | PubMed |
| Development and function of the fetal adrenal. | Rev Endocr Metab Disord | 2023 | 36255414 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Targeted Brain Delivery of Dendrimer-4-Phenylbutyrate Ameliorates Neurological Deficits in a Long-Term ABCD1-Deficient Mouse Model of X-Linked Adrenoleukodystrophy. | Neurotherapeutics | 2023 | 36207570 | PubTator, text mining | PubMed |
| Modular cytokine receptor-targeting chimeras for targeted degradation of cell surface and extracellular proteins. | Nat Biotechnol | 2023 | 36138170 | PubTator, text mining | PubMed |
| The performance of genome sequencing as a first-tier test for neurodevelopmental disorders. | Eur J Hum Genet | 2023 | 36114283 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/215/papers?page=18